“We were established in Switzerland in 2021 and have since expanded internationally, with a global headquarters and 501(c)(3) status in the United States. The organization was founded by Garri Zmudze, Ilya Suharenko and Sergey Jakimov. Following years of experience in the longevity space, our initial team recognized a two-fold need: 1) there was a distinct lack of funding available for cutting-edge longevity research in its earliest phases, and 2) existing funding bodies had unclear funding processes in place. To remove these barriers, the founders created LSF to provide grant funding for projects too early in development for venture capital or other traditional investments. Our funding process is entirely transparent, with donors receiving voting rights to participate in selecting our funded projects,” said Lisa E. Ireland, President and CEO of the Longevity Science Foundation.

“The LSF's employees are based worldwide, with backgrounds as diverse as our passports. Hailing from the nonprofit, investing, engineering, law, and business sectors, we possess a unique skill set to hone our work and advance our mission. We are a small team with big goals, and we look forward to welcoming new members to the LSF team as we expand our presence in the near future,”  Lisa says describing the Foundation’s team and future.“We are proud to be a growing organization, helping provide more funding and connecting with new donors. In late 2021, we announced the further expansion of LSF into the United States with our new global headquarters in Miami, Florida. Our work in the coming year will focus on establishing new partnerships, announcing our first funded projects, building connections around new research areas like psychedelics, and continuing our fundraising workto support more research grants,” Lisa continued.

“We are currently reviewing our first round of funding proposals for projects related to aging clocks and other longevity adjacent areas, of which we have received more than 100 to date. After being vetted by our expert Visionary Board, our donors will vote on their top choices and select final projects for LSF support. Our second funding call for psychedelic mental health applications is open until June 30th. We plan to launch additional calls on other vital topics every year,” Lisa said

“All of our funded projects are evaluated for their impact potential. We specifically look for projects that are likely to reach human use within the next five years. An example of this is our funding call on psychedelic mental health treatments, which can help treat difficult mentalhealth conditions like PTSD and addiction,” Lisa explains.

“We are also excited to support cutting-edge research at its source by partnering with globally renowned educational institutions. By supporting researchers and students, we will help shape the future of longevity-centered curricula and educational programs,” Lisa added.

We are developing our outreach and working with new stakeholders to increase knowledge sharing and awareness around the value of early-stage research. Specifically, the Wois grant empowered us to back an initiative dedicated to promoting longevity education amongst practicing physicians in the space,” Lisa summarized.